Regeneron(REGN) - 2023 Q4 - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Conference Call February 2, 2024 8:30 AM ET Company Participants Ryan Crowe - Senior Vice President, Investor Relations Leonard Schleifer - President and Chief Executive Officer George Yancopoulos - Co-Chair, Co-Founder, President and Chief Scientific Officer Marion McCourt - Executive Vice President and Head of Commercial Bob Landry - Executive Vice President and Chief Financial Officer Conference Call Participants Tyler Van Buren - TD Cowen Br ...